The Klinique Medical Clinic PCL (BKK:KLINIQ)

Thailand · Delayed Price · Currency is THB

29.00

+0.50 (1.75%)

Aug 10, 2026, 4:36 PM ICT

16.00% (1Y)

Market Cap	6.38B +16.0%
Revenue (ttm)	3.83B +23.1%
Net Income	400.03M +20.6%
EPS	1.82 +20.6%
Shares Out	220.00M
PE Ratio	15.95
Forward PE	14.25
Dividend	1.45 (5.09%)
Ex-Dividend Date	Apr 29, 2026

Volume	218,923
Open	29.00
Previous Close	28.50
Day's Range	29.00 - 29.00
52-Week Range	19.60 - 30.50
Beta	0.33
Analysts	Buy
Price Target	31.33 (+8.03%)
Earnings Date	Aug 14, 2026

About BKK:KLINIQ

The Klinique Medical Clinic Public Company Limited provides skin medical treatment services under the Klinique brand name in Thailand. Its services include face lift, acne, pimples, and acne scars, skin tightening, filler, fat dissolving injection, laser hair removal, skin treatment, skin injection, mesofront, mesotherapy, and rhinoplasty, as well as nose, eye, and facial surgery. The company also offers skin medical services and distribution of cosmetics and medical cosmetics, and surgery services. The Klinique Medical Clinic Public Company Li... [Read more]

Industry Personal Services

Sector Consumer Discretionary

Founded 2009

Employees 526

Stock Exchange Stock Exchange of Thailand

Ticker Symbol KLINIQ

Full Company Profile

Financial Performance

In 2025, BKK:KLINIQ's revenue was 3.56 billion, an increase of 19.22% compared to the previous year's 2.98 billion. Earnings were 363.70 million, an increase of 12.88%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for KLINIQ stock is "Buy." The 12-month stock price target is ฿31.33, which is an increase of 8.03% from the latest price.

Price Target

฿31.33

(8.03% upside)

Analyst Consensus: Buy

Stock Forecasts